In terms of economic attractiveness, a small example always says more than a great speech by our ministers.
This is the case with Moderna's wanderings in Europe.
Stéphane Bancel, the French boss of the new vaccine giant, toured European capitals in the spring to decide where he would set up his factory.
A few days before the presidential election, he did not fail to meet the French authorities, the very ones who swore to do everything to ensure that our country regains its place in the world pharmacy.
To discover
Taxes 2022: all about your tax return
Read also
Vaccines: how BioNTech and Moderna are preparing for the post-Covid period
The decision has just fallen: Moderna has finally chosen Great Britain.
Boris Johnson rolled out the red carpet and found the (financial) arguments for the champion of messenger RNA to invest nearly 1 billion euros in a factory and a research and development center in the United Kingdom.
Suffice to say that this is a new failure for our leaders who had already failed to convince Elon Musk to build his European factory…
This article is for subscribers only.
You have 76% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for €0.99 for the first month
I ENJOY IT
Already subscribed?
Login
